What attracted you to the health metrics field?
I became interested in the field of health metrics when my personal experiences highlighted the lack of information in diagnosing and understanding mental illnesses – particularly in minority communities. After becoming more conscious of this worldview, I began to notice how health outreach services were largely nonexistent for these less mainstream, controversial, and stigmatized illnesses. Without this vital information, illnesses are unaddressed and all too many live without achieving their full health and happiness potentials. This sparked my interest in understanding and analyzing health data metrics.
What work are you doing at IHME?
This year I am working on the Global Burden of Disease team – disease estimation for skin and digestive disorders for GBD 2016.
How do you think your experience at IHME will contribute to your future work?
While I am unsure of where I will be in the future, I am currently interested in understanding and maximizing efficiency in health delivery systems and public health programs. I am also trying to find a personal balance between behind-the-scenes research, and being a practitioner working with individuals and communities. Nonetheless, I am confident that my experience at IHME will provide me with a strong technical foundation that will be invaluable in my future.
GBD 2016 Healthcare Access and Quality Collaborators. Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016. The Lancet. 23 May 2018.
US Burden of Disease Collaborators. The State of US Health, 1990-2016: Burden of Diseases, Injuries, and Risk Factors Among US States. JAMA. 10 April 2018; 319(14):1-33. doi:10.1001/jama.2018.0158
GBD 2016 Causes of Death Collaborators. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 14 Sept 2017: 390;1151–210.
GBD 2016 DALYs and HALE Collaborators. Global, regional, and national disability-adjusted life years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 14 Sept 2017: 390;1260-344.
GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet. 14 Sept 2017: 390; 1211–59.
GBD 2016 SDG Collaborators. Measuring progress and projecting attainment on the basis of past trends of the health-related Sustainable Development Goals in 188 countries: an analysis from the Global Burden of Disease Study 2016. The Lancet. 12 Sept 2017: 390; 1423–59.